Transdiagnostic use of 3,4-methylenedioxymethamphetamine-assisted therapy to treat obsessive-compulsive disorder.
Ziad Saade, Alex S Keuroghlian
The British journal of psychiatry : the journal of mental science February 26, 2025 DOI: 10.1192/bjp.2024.277 via PubMed
Summary
AI-generated from the abstractMDMA-assisted therapy may improve exposure and response prevention for obsessive-compulsive disorder by enhancing fear extinction, psychological flexibility, and empathy, potentially boosting treatment adherence and effectiveness. The article discusses these mechanisms and emphasizes safety considerations for future research.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | exposure and response prevention |
| Topics | Psychedelic-assisted therapy |
| Keywords | Neuroscience Obsessive–compulsive disorders Psychological treatments Psychotherapy |
| Citations | 2 |
| Key finding | MDMA-assisted therapy may enhance exposure and response prevention for OCD through fear extinction, psychological flexibility, and empathogenic effects. |
Abstract
This article explores the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy to enhance exposure and response prevention in obsessive-compulsive disorder treatment. We discuss the mechanisms of MDMA, including fear extinction, psychological flexibility, and empathogenic effects that may improve adherence and efficacy, as well as highlighting important safety considerations for further research.